This website describes Equisculpt Novem Fund — the brand name of Novem Prime Incorporated VCC Sub-Fund, a sub-fund of the umbrella vehicle Equisculpt Novem Capital VCC, a Mauritius variable capital company holding a Global Business Licence issued by the Financial Services Commission, Mauritius. It is provided for information only and does not constitute an offer, solicitation or investment advice.
The fund is available exclusively to eligible investors who meet applicable qualification requirements, on the basis of its confidential offering documents. It is not open to residents of India under the Indian FEMA and SEBI FPI frameworks, and nothing on this site is directed at any person in a jurisdiction where such distribution would be unlawful.
Past performance — including the track record of related entities — is not indicative of future results. Investment involves risk, including possible loss of capital.
Novem does not compete in efficient markets. The fund invests where a company is crossing a threshold — of ownership, liquidity, information or listing status — because it is at these crossings that price and value separate most widely.
The largest single re-pricing event in a company’s life. Pre-IPO and anchor entry positions capital before the market sets the price — at negotiated valuations unavailable to any public-market investor.
Sub-₹2,000 crore companies are held by promoters and retail. When institutions arrive — index inclusion, FII/DII eligibility thresholds, coverage initiation — the shareholder register re-rates the stock. Novem enters before that arrival.
Illiquidity is a discount that disappears as float, volumes and market-making deepen. Positions are entered where liquidity is thin but improving — and the improvement itself is part of the return.
Companies with no analyst coverage are priced on incomplete information. Proprietary research — promoter access, channel checks, on-ground intelligence — captures the gap between what is knowable and what is priced.
Earnings growth alone is not the thesis; the multiple expanding as the market re-categorises the company is. Each position must have an identifiable re-rating catalyst, not merely a growth forecast.
A transition thesis fails without discipline on both ends. Novem’s operating rules are absolute, not aspirational.
Each strategy is the transitions thesis applied to a different point on India’s private-to-public spectrum.
Anchor allocations price the private-to-public crossing; small & micro-cap listed positions ride the ownership and information transitions that follow it. Strategy A →
Pre-IPO secondaries enter before the gate at negotiated discounts; selective mid-caps capture the later re-rating as institutional eligibility thresholds approach. Strategy D →
Special situations — forced selling, corporate actions, rights and preferential issues — are transitions compressed into events, taken opportunistically. Strategy E →